1
|
Cristani M, Micale N. Bioactive Compounds from Medicinal Plants as Potential Adjuvants in the Treatment of Mild Acne Vulgaris. Molecules 2024; 29:2394. [PMID: 38792254 PMCID: PMC11124055 DOI: 10.3390/molecules29102394] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2024] [Revised: 05/15/2024] [Accepted: 05/17/2024] [Indexed: 05/26/2024] Open
Abstract
In recent years, there has been a growing interest in the use of medicinal plants and phytochemicals as potential treatments for acne vulgaris. This condition, characterized by chronic inflammation, predominantly affects adolescents and young adults. Conventional treatment typically targets the key factors contributing to its development: the proliferation of Cutibacterium acnes and the associated inflammation. However, these treatments often involve the use of potent drugs. As a result, the exploration of herbal medicine as a complementary approach has emerged as a promising strategy. By harnessing the therapeutic properties of medicinal plants and phytochemicals, it may be possible to address acne vulgaris while minimizing the reliance on strong drugs. This approach not only offers potential benefits for individuals seeking alternative treatments but also underscores the importance of natural remedies of plant origin in dermatological care. The primary aim of this study was to assess the antimicrobial, antioxidant, and anti-inflammatory properties of plants and their phytochemical constituents in the management of mild acne vulgaris. A comprehensive search of scientific databases was conducted from 2018 to September 2023. The findings of this review suggest that medicinal plants and their phytochemical components hold promise as treatments for mild acne vulgaris. However, it is crucial to note that further research employing high-quality evidence and standardized methodologies is essential to substantiate their efficacy and safety profiles.
Collapse
Affiliation(s)
| | - Nicola Micale
- Dipartimento di Scienze Chimiche, Biologiche, Farmaceutiche ed Ambientali, Università di Messina, Viale F. Stagno D’Alcontres 31, I-98166 Messina, Italy;
| |
Collapse
|
2
|
Filipe M, Domínguez-Martín EM, Pires TCP, Finimundy TC, Melgar B, Mandim F, Isca VMS, Pereira R, Teixidó-Trujillo S, Capote NA, Nikolić M, Filipović N, Díaz-Lanza AM, Figueiredo AC, Barros L, Rijo P. Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton. ACS OMEGA 2024; 9:18113-18118. [PMID: 38680304 PMCID: PMC11044231 DOI: 10.1021/acsomega.3c10071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 12/16/2023] [Revised: 03/14/2024] [Accepted: 03/27/2024] [Indexed: 05/01/2024]
Abstract
The Plectranthus genus (Lamiaceae) is known to be rich in abietane diterpenes. The bioactive 6,7-dehydroxyroyleanone (DHR, 1) was previously isolated from Plectranthus madagascariensis var. madagascariensis and var. aliciae. This study aimed to explore the occurrence of DHR, 1, in P. aliciae and the potential bioactivities of new semisynthetic derivatives from DHR, 1. Several extraction methods were evaluated, and the hydrodistillation, using a Clevenger apparatus, afforded the highest yield (77.8 mg/g of 1 in the essential oil). Three new acyl derivatives (2-4) were successfully prepared from 1 (yields of 86-95%). Compounds 1-4 showed antioxidant activity, antibacterial effects, potent cytotoxic activity against several cell lines, and enhanced anti-inflammatory activity that surpassed dexamethasone (positive control). These findings encourage further exploration of derivatives 2-4 for potential mechanisms of antitumoral, antioxidant, and anti-inflammatory capabilities, studying both safety and efficacy.
Collapse
Affiliation(s)
- Márcia
S. Filipe
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Eva M. Domínguez-Martín
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Tânia C.
S. P. Pires
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Tiane C. Finimundy
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Bruno Melgar
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Filipa Mandim
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Vera M. S. Isca
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
| | - Raquel Pereira
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
| | - Silvia Teixidó-Trujillo
- Centro Atlántico
del Medicamento S.A., Avenida Trinidad 61, 7a Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain
| | - Natalia A. Capote
- Centro Atlántico
del Medicamento S.A., Avenida Trinidad 61, 7a Planta, Torre Agustín Arévalo, 38204 La Laguna, Tenerife, Spain
| | - Milan Nikolić
- Faculty
of Chemistry, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia
| | - Nenad Filipović
- Faculty
of Agriculture, University of Belgrade, Nemanjina 6, 11000 Belgrade, Serbia
| | - Ana M. Díaz-Lanza
- Departamento
de Ciencias Biomédicas (Área de Farmacología,
Nuevos agentes antitumorales, Acción tóxica sobre células
leucémicas), Facultad de Farmacia, Universidad de Alcalá de Henares, 28805 Madrid, España
| | - Ana Cristina Figueiredo
- Centro
de Estudos do Ambiente e do Mar (CESAM Ciências), Faculdade
de Ciências, Universidade de Lisboa
(FCUL), Biotecnologia Vegetal, DBV, C2, Campo Grande, 1749-016 Lisboa, Portugal
| | - Lillian Barros
- Centro
de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253 Bragança, Portugal
- Laboratório
Associado para a Sustentabilidade e Tecnologia em Regiões de
Montanha (SusTEC), Instituto Politécnico
de Bragança, Campus
de Santa Apolónia, 5300-253 Braganca, Portugal
| | - Patrícia Rijo
- CBIOS-Universidade
Lusófona’s Research Center for Biosciences & Health
Technologies, Campo Grande 376, 1749-024 Lisbon, Portugal
- Instituto
de Investigação do Medicamento (iMed.ULisboa), Faculdade
de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
| |
Collapse
|
3
|
Merecz-Sadowska A, Isca VMS, Sitarek P, Kowalczyk T, Małecka M, Zajdel K, Zielińska-Bliźniewska H, Jęcek M, Rijo P, Zajdel R. Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach. Int J Mol Sci 2024; 25:4529. [PMID: 38674113 PMCID: PMC11050557 DOI: 10.3390/ijms25084529] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 04/07/2024] [Accepted: 04/18/2024] [Indexed: 04/28/2024] Open
Abstract
The diterpene 7α-acetoxy-6β-hydroxyroyleanone isolated from Plectranthus grandidentatus demonstrates promising antibacterial, anti-inflammatory and anticancer properties. However, its bioactivity may be enhanced via strategic structural modifications of such natural products through semisynthesis. The anticancer potential of 7α-acetoxy-6β-hydroxyroyleanone and five derivatives was analyzed in silico via the prediction of chemicals absorption, distribution, metabolism, excretion, and toxicity (ADMET), quantum mechanical calculations, molecular docking and molecular dynamic simulation. The protein targets included regulators of apoptosis and cell proliferation. Additionally, network pharmacology was used to identify potential targets and signaling pathways. Derivatives 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone achieved high predicted binding affinities towards their respective protein panels, with stable molecular dynamics trajectories. Both compounds demonstrated favorable ADMET parameters and toxicity profiles. Their stability and reactivity were confirmed via geometry optimization. Network analysis revealed their involvement in cancer-related pathways. Our findings justify the inclusion of 7α-acetoxy-6β-hydroxy-12-O-(2-fluoryl)royleanone and 7α-acetoxy-6β-(4-fluoro)benzoxy-12-O-(4-fluoro)benzoylroyleanone in in vitro analyses as prospective anticancer agents. Our binding mode analysis and stability simulations indicate their potential as selective inhibitors. The data will guide studies into their structure optimization, enhancing efficacy and drug-likeness.
Collapse
Affiliation(s)
- Anna Merecz-Sadowska
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (M.J.); (R.Z.)
- Department of Allergology and Respiratory Rehabilitation, Medical University of Lodz, 90-725 Lodz, Poland;
| | - Vera M. S. Isca
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisboa, Portugal;
| | - Przemysław Sitarek
- Department of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland;
| | - Tomasz Kowalczyk
- Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland;
| | - Magdalena Małecka
- Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland;
| | - Karolina Zajdel
- Department of Medical Informatics and Statistics, Medical University of Lodz, 90-645 Lodz, Poland;
| | | | - Mariusz Jęcek
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (M.J.); (R.Z.)
| | - Patricia Rijo
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisboa, Portugal;
- Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisboa, Portugal
| | - Radosław Zajdel
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (M.J.); (R.Z.)
- Department of Medical Informatics and Statistics, Medical University of Lodz, 90-645 Lodz, Poland;
| |
Collapse
|
4
|
Isca VMS, Sitarek P, Merecz-Sadowska A, Małecka M, Owczarek M, Wieczfińska J, Zajdel R, Nowak P, Rijo P, Kowalczyk T. Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach. Molecules 2024; 29:1807. [PMID: 38675627 PMCID: PMC11052076 DOI: 10.3390/molecules29081807] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2024] [Revised: 03/30/2024] [Accepted: 04/10/2024] [Indexed: 04/28/2024] Open
Abstract
The abietane diterpenoid 7α-acetoxy-6β-hydroxyroyleanone (Roy) isolated from Plectranthus grandidentatus demonstrates cytotoxicity across numerous cancer cell lines. To potentiate anticancer attributes, a series of semi-synthetic Roy derivatives were generated and examined computationally. ADMET predictions were used to evaluate drug-likeness and toxicity risks. The antineoplastic potential was quantified by PASS. The DFT models were used to assess their reactivity and stability. Molecular docking determined cancer-related protein binding. MS simulations examined ligand-protein stability. Additionally, network pharmacology was used to identify potential targets and signaling pathways. Favorable ADME attributes and acceptable toxicity profiles were determined for all compounds. Strong anticancer potential was shown across derivatives (Pa 0.819-0.879). Strategic modifications altered HOMO-LUMO gaps (3.39-3.79 eV) and global reactivity indices. Favorable binding was revealed against cyclin-dependent kinases, BCL-2, caspases, receptor tyrosine kinases, and p53. The ligand exhibited a stable binding pose in MD simulations. Network analysis revealed involvement in cancer-related pathways. In silico evaluations predicted Roy and derivatives as effective molecules with anticancer properties. Experimental progress is warranted to realize their chemotherapeutic potential.
Collapse
Affiliation(s)
- Vera M. S. Isca
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal;
| | - Przemysław Sitarek
- Department of Medical Biology, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland;
| | - Anna Merecz-Sadowska
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (A.M.-S.); (R.Z.); (P.N.)
- Department of Allergology and Respiratory Rehabilitation, Medical University of Lodz, 90-725 Lodz, Poland
| | - Magdalena Małecka
- Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, 90-236 Lodz, Poland;
| | - Monika Owczarek
- Łukasiewicz Research Network, Lodz Institute of Technology, Skłodowskiej-Curie 19/27, 90-570 Lodz, Poland;
| | - Joanna Wieczfińska
- Department of Immunopathology, Medical University of Lodz, Zeligowskiego 7/9, 90-752 Lodz, Poland;
| | - Radosław Zajdel
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (A.M.-S.); (R.Z.); (P.N.)
- Department of Medical Informatics and Statistics, Medical University of Lodz, 90-645 Lodz, Poland
| | - Paweł Nowak
- Department of Economic and Medical Informatics, University of Lodz, 90-214 Lodz, Poland; (A.M.-S.); (R.Z.); (P.N.)
| | - Patricia Rijo
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal;
- Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, 1649-003 Lisbon, Portugal
| | - Tomasz Kowalczyk
- Department of Molecular Biotechnology and Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland
| |
Collapse
|
5
|
Targeting Acne Bacteria and Wound Healing In Vitro Using Plectranthus aliciae, Rosmarinic Acid, and Tetracycline Gold Nanoparticles. Pharmaceuticals (Basel) 2022; 15:ph15080933. [PMID: 36015081 PMCID: PMC9412649 DOI: 10.3390/ph15080933] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2022] [Revised: 07/03/2022] [Accepted: 07/08/2022] [Indexed: 12/01/2022] Open
Abstract
Gold nanoparticles from plant extracts and their bioactive compounds to treat various maladies have become an area of interest to many researchers. Acne vulgaris is an inflammatory disease of the pilosebaceous unit caused by the opportunistic bacteria Cutibacterium acnes and Staphylococcus epidermis. These bacteria are not only associated with inflammatory acne but also with prosthetic-implant-associated infections and wounds. Studies have hypothesised that these bacteria have a mutualistic relationship and act as a multispecies system. It is believed that these bacteria form a multispecies biofilm under various conditions and that these biofilms contribute to increased antibiotic resistance compared to single-species biofilms. This study aimed to investigate the antibacterial and wound healing potential of synthesised gold nanoparticles (AuNPs) from an endemic South African plant, Plectranthus aliciae (AuNPPAE), its major compound rosmarinic acid (AuNPRA) and a widely used antibiotic, tetracycline (AuNPTET). Synthesised gold nanoparticles were successfully formed and characterised using ultraviolet–visible spectroscopy (UV–vis), dynamic light scattering (DLS), Fourier transform infrared spectroscopy (FTIR), zeta potential (ζ-potential), high-resolution transmission electron microscopy (HRTEM), and selected area electron diffraction (SAED), and they were investigated for stability under various biological conditions. Stable nanoparticles were formed with ζ-potentials of −18.07 ± 0.95 mV (AuNPPAE), −21.5 ± 2.66 mV (AuNPRA), and −39.83 ± 1.6 mV (AuNPTET). The average diameter of the AuNPs was 71.26 ± 0.44 nm, 29.88 ± 3.30 nm, and 132.6 ± 99.5 nm for AuNPPAE, AuNPRA, and AuNPTET, respectively. In vitro, biological studies confirmed that although no antibacterial activity or biofilm inhibition was observed for the nanoparticles tested on the multispecies C. acnes and S. epidermis systems, these samples had potential wound closure activity. Gold nanoparticles formed with rosmarinic acid significantly increased wound closure by 21.4% at 25% v/v (≈29.2 µg/mL) compared to the negative cell control and the rosmarinic acid compound at the highest concentration tested of 500 µg/mL. This study concluded that green synthesised gold nanoparticles of rosmarinic acid could potentially be used for treating wounds.
Collapse
|
6
|
Domínguez-Martín EM, Magalhães M, Díaz-Lanza AM, Marques MP, Princiotto S, Gómez AM, Efferth T, Cabral C, Rijo P. Phytochemical Study and Antiglioblastoma Activity Assessment of Plectranthus hadiensis (Forssk.) Schweinf. ex Sprenger var. hadiensis Stems. MOLECULES (BASEL, SWITZERLAND) 2022; 27:molecules27123813. [PMID: 35744938 PMCID: PMC9230782 DOI: 10.3390/molecules27123813] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/24/2022] [Revised: 06/10/2022] [Accepted: 06/11/2022] [Indexed: 11/22/2022]
Abstract
Glioblastoma (GB) is the most malignant form of primary astrocytoma, accounting for more than 60% of all brain tumors in adults. Nowadays, due to the development of multidrug resistance causing relapses to the current treatments and the development of severe side effects resulting in reduced survival rates, new therapeutic approaches are needed. The genus Plectranthus belongs to the Lamiaceae family and is known to be rich in abietane-type diterpenes, which possess antitumor activity. Specifically, P. hadiensis (Forssk.) Schweinf. ex Sprenger has been documented for the use against brain tumors. Therefore, the aim of this work was to perform the bioguided isolation of compounds from the acetonic extract of P. hadiensis stems and to investigate the in vitro antiglioblastoma activity of the extract and its isolated constituents. After extraction, six fractions were obtained from the acetonic extract of P. hadiensis stems. In a preliminary biological screening, the fractions V and III showed the highest antioxidant and antimicrobial activities. None of the fractions were toxic in the Artemia salina assay. We obtained different abietane-type diterpenes such as 7α-acetoxy-6β-hydroxyroyleanone (Roy) and 6β,7β-dihydroxyroyleanone (DiRoy), which was also in agreement with the HPLC-DAD profile of the extract. Furthermore, the antiproliferative activity was assessed in a glioma tumor cell line panel by the Alamar blue assay. After 48 h treatment, Roy exerted strong antiproliferative/cytotoxic effects against tumor cells with low IC50 values among the different cell lines. Finally, we synthesized a new fluorescence derivative in this study to evaluate the biodistribution of Roy. The uptake of BODIPY-7α-acetoxy-6β-hydroxyroyleanone by GB cells was associated with increased intracellular fluorescence, supporting the antiproliferative effects of Roy. In conclusion, Roy is a promising natural compound that may serve as a lead compound for further derivatization to develop future therapeutic strategies against GB.
Collapse
Affiliation(s)
- Eva María Domínguez-Martín
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
- New Antitumor Compounds—Toxic Action on Leukemia Cells Research Group, Pharmacology Area (Pharmacognosy Laboratory), Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100—Campus Universitario, Alcalá de Henares, 28805 Madrid, Spain;
| | - Mariana Magalhães
- PhD Programme in Experimental Biology and Biomedicine, Institute for Interdisciplinary Research (IIIUC), University of Coimbra, Casa Costa Alemão, 3030-789 Coimbra, Portugal;
- CNC—Center for Neuroscience and Cell Biology, University of Coimbra, 3004-516 Coimbra, Portugal
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
| | - Ana María Díaz-Lanza
- New Antitumor Compounds—Toxic Action on Leukemia Cells Research Group, Pharmacology Area (Pharmacognosy Laboratory), Department of Biomedical Sciences, Faculty of Pharmacy, University of Alcalá de Henares, Ctra. A2, Km 33.100—Campus Universitario, Alcalá de Henares, 28805 Madrid, Spain;
| | - Mário P. Marques
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
| | - Salvatore Princiotto
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
| | - Ana M. Gómez
- Instituto de Química Orgánica, IQOG-CSIC, Juan de la Cierva 3, 28006 Madrid, Spain;
| | - Thomas Efferth
- Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany;
| | - Célia Cabral
- Faculty of Medicine, Clinic Academic Center of Coimbra (CACC), Coimbra Institute for Clinical and Biomedical Research (iCBR), University of Coimbra, 3000-548 Coimbra, Portugal;
- Center for Innovative Biomedicine and Biotechnology (CIBB), University of Coimbra, 3000-548 Coimbra, Portugal
- Centre for Functional Ecology, Department of Life Sciences, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal
- Correspondence: (C.C.); (P.R.)
| | - Patricia Rijo
- Center for Research in Biosciences & Health Technologies (CBIOS), Universidade Lusófona de Humanidades e Tecnologias, Campo Grande 376, 1749-024 Lisbon, Portugal; (E.M.D.-M.); (S.P.)
- Instituto de Investigação do Medicamento (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal
- Correspondence: (C.C.); (P.R.)
| |
Collapse
|
7
|
Saha P, Rahman FI, Hussain F, Rahman SMA, Rahman MM. Antimicrobial Diterpenes: Recent Development From Natural Sources. Front Pharmacol 2022; 12:820312. [PMID: 35295739 PMCID: PMC8918777 DOI: 10.3389/fphar.2021.820312] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 12/30/2021] [Indexed: 12/12/2022] Open
Abstract
Antimicrobial resistance has been posing an alarming threat to the treatment of infectious diseases over the years. Ineffectiveness of the currently available synthetic and semisynthetic antibiotics has led the researchers to discover new molecules with potent antimicrobial activities. To overcome the emerging antimicrobial resistance, new antimicrobial compounds from natural sources might be appropriate. Secondary metabolites from natural sources could be prospective candidates in the development of new antimicrobial agents with high efficacy and less side effects. Among the natural secondary metabolites, diterpenoids are of crucial importance because of their broad spectrum of antimicrobial activity, which has put it in the center of research interest in recent years. The present work is aimed at reviewing recent literature regarding different classes of natural diterpenes and diterpenoids with significant antibacterial, antifungal, antiviral, and antiprotozoal activities along with their reported structure-activity relationships. This review has been carried out with a focus on relevant literature published in the last 5 years following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A total of 229 diterpenoids from various sources like plants, marine species, and fungi are summarized in this systematic review, including their chemical structures, classification, and significant antimicrobial activities together with their reported mechanism of action and structure-activity relationships. The outcomes herein would provide researchers with new insights to find new credible leads and to work on their synthetic and semisynthetic derivatives to develop new antimicrobial agents.
Collapse
Affiliation(s)
- Poushali Saha
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Imtiaz Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - Fahad Hussain
- Department of Pharmacy, Noakhali Science and Technology University, Noakhali, Bangladesh
| | - S. M. Abdur Rahman
- Faculty of Pharmacy, Department of Clinical Pharmacy and Pharmacology, University of Dhaka, Dhaka, Bangladesh
| | - M. Mukhlesur Rahman
- Medicines Research Group, School of Health, Sports and Bioscience, University of East London, London, United Kingdom
| |
Collapse
|
8
|
Rodrigues FFG, Boligon AA, Menezes IRA, Galvão-Rodrigues FF, Salazas GJT, Nonato CFA, Braga NTTM, Correia FMA, Caldas GFR, Coutinho HDM, Siyadatpanah A, Kim B, Costa JGM, Barros ARC. HPLC/DAD, Antibacterial and Antioxidant Activities of Plectranthus Species (Lamiaceae) Combined with the Chemometric Calculations. Molecules 2021; 26:molecules26247665. [PMID: 34946747 PMCID: PMC8703593 DOI: 10.3390/molecules26247665] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2021] [Revised: 12/13/2021] [Accepted: 12/15/2021] [Indexed: 11/16/2022] Open
Abstract
The increase in antibiotic resistance and the emergence of new bacterial infections have intensified the research for natural products from plants with associated therapy. This study aimed to verify the antibacterial and antioxidant activity of crude extracts of the genus Plectranthus species, being the first report on the modulation of aminoglycosides antibiotic activity by Plectranthus amboinicus extracts. The chemical composition was obtained by chemical prospecting and High-Performance Liquid Chromatography with diode arrangement detector (HPLC/DAD). The antibacterial activities of the extracts alone or in association with aminoglycosides were analyzed using the microdilution test. The antioxidant activity was evaluated by 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical scavenging. The phytochemical prospection allowed the flavonoids, saponins, tannins and triterpenoids to be identified. Quercetin, rutin, gallic acid, chlorogenic acid, caffeic acid, catechin, kaempferol, glycosylated kaempferol, quercitrin, and isoquercitrin were identified and quantified. The principal component analysis (PCA) observed the influence of flavonoids and phenolic acids from Plectranthus species on studied activities. Phytochemical tests with the extracts indicated, especially, the presence of flavonoids, confirmed by quantitative analysis by HPLC. The results revealed antibacterial activities, and synergistic effects combined with aminoglycosides, as well as antioxidant potential, especially for P. ornatus species, with IC50 of 32.21 µg/mL. Multivariate analyzes show that the inclusion of data from the antioxidant and antibacterial activity suggests that the antioxidant effect of these species presents a significant contribution to the synergistic effect of phytoconstituents, especially based on the flavonoid contents. The results of this study suggest the antibacterial activity of Plectranthus extracts, as well as their potential in modifying the resistance of the analyzed aminoglycosides.
Collapse
Affiliation(s)
- Fabíola F. G. Rodrigues
- Northeast Biotechnology Network, Postgraduate Program in Biotechnology, State University of Ceará, Fortaleza 60740-000, Brazil; (F.F.G.R.); (I.R.A.M.); (H.D.M.C.); (A.R.C.B.)
- Health Unit, University Center Dr. Leão Sampaio, Juazeiro do Norte 63040-000, Brazil; (N.T.T.M.B.); (F.M.A.C.); (G.F.R.C.)
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Aline A. Boligon
- Department of Industrial Pharmacy, Federal University of Santa Maria, Santa Maria 97105-900, Brazil;
| | - Irwin R. A. Menezes
- Northeast Biotechnology Network, Postgraduate Program in Biotechnology, State University of Ceará, Fortaleza 60740-000, Brazil; (F.F.G.R.); (I.R.A.M.); (H.D.M.C.); (A.R.C.B.)
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Fábio F. Galvão-Rodrigues
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Gerson J. T. Salazas
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Carla F. A. Nonato
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Nara T. T. M. Braga
- Health Unit, University Center Dr. Leão Sampaio, Juazeiro do Norte 63040-000, Brazil; (N.T.T.M.B.); (F.M.A.C.); (G.F.R.C.)
| | - Fabrina M. A. Correia
- Health Unit, University Center Dr. Leão Sampaio, Juazeiro do Norte 63040-000, Brazil; (N.T.T.M.B.); (F.M.A.C.); (G.F.R.C.)
| | - Germana F. R. Caldas
- Health Unit, University Center Dr. Leão Sampaio, Juazeiro do Norte 63040-000, Brazil; (N.T.T.M.B.); (F.M.A.C.); (G.F.R.C.)
| | - Henrique D. M. Coutinho
- Northeast Biotechnology Network, Postgraduate Program in Biotechnology, State University of Ceará, Fortaleza 60740-000, Brazil; (F.F.G.R.); (I.R.A.M.); (H.D.M.C.); (A.R.C.B.)
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
| | - Abolghasem Siyadatpanah
- Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, Birjand 9717853577, Iran
- Correspondence: (A.S.); (B.K.); (J.G.M.C.)
| | - Bonglee Kim
- Department of Patology, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea
- Korean Medicine-Based Drug Repositioning Cancer Research Center, College of Korean Medicine, Kyung Hee University, Seoul 02447, Korea
- Correspondence: (A.S.); (B.K.); (J.G.M.C.)
| | - José G. M. Costa
- Northeast Biotechnology Network, Postgraduate Program in Biotechnology, State University of Ceará, Fortaleza 60740-000, Brazil; (F.F.G.R.); (I.R.A.M.); (H.D.M.C.); (A.R.C.B.)
- Department of Biological Chemistry, Regional University of Cariri, Crato 63105-000, Brazil; (F.F.G.-R.); (G.J.T.S.); (C.F.A.N.)
- Correspondence: (A.S.); (B.K.); (J.G.M.C.)
| | - Adriana R. C. Barros
- Northeast Biotechnology Network, Postgraduate Program in Biotechnology, State University of Ceará, Fortaleza 60740-000, Brazil; (F.F.G.R.); (I.R.A.M.); (H.D.M.C.); (A.R.C.B.)
- Experimental Biology Nucleus, University of Fortaleza, Fortaleza 60811-905, Brazil
| |
Collapse
|